News

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Viking Therapeutics, Inc. (VKTX) closed at $28.19 in the latest trading session, marking a +1.7% move from the prior day.
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific ...
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
Casper, Wyoming Community News Stream.Voting for Oil City’s Best 2025 is NOW OPEN! We’re celebrating all the Stuff Locals Love! VOTE NOW for your favorite Casper-area people, places and things below!
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target of $102.00. The company’s shares ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...